Effect of Huangqi Shengmai Yin on myocardial fibrosis in rats with acute myocardial infarction by adjusting P2X7R/NLRP3 pathway

MA Yi-jie ZHANG You-jian WANG Ji-pei LI Dan-dan JIN Jin-ge

Acta Anatomica Sinica ›› 2025, Vol. 56 ›› Issue (6) : 713-720.

PDF(3812 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(3812 KB)
Acta Anatomica Sinica ›› 2025, Vol. 56 ›› Issue (6) : 713-720. DOI: 10.16098/j.issn.0529-1356.2025.06.011
Histology and embryology and Developmental Biology

Effect of Huangqi Shengmai Yin on myocardial fibrosis in rats with acute myocardial infarction by adjusting P2X7R/NLRP3 pathway

  • MA Yi-jie* ZHANG You-jian WANG Ji-pei LI Dan-dan JIN Jin-ge
Author information +
History +

Abstract

Objective To investigate the effect of Huangqi Shengmai Yin (HSY) on myocardial fibrosis in rats with acute myocardial infarction (AMI) by adjusting P2X purinoceptor 7 (P2X7R)/NOD-like receptor protein 3 (NLRP3) pathway.    Methods Sixty rats were divied into a sham operation group and model group(5 groups), with 10 rats in each group. The AMI rat model was constructed by ligating the left anterior descending branch and randomly grouped into AMI group, the HSY-low group (intragastric administration of 1.6 ml/kg HSY), the HSY group (intragastric administration of 6.2 ml/kg HSY), the compound miltiorhiza group (intragastric administration of 300 mg/kg), and the HSY-high+P2X7R agonist-ATP group (intragastric administration of 6.2 ml/kg HSY, and tail vein administration of 10 mmol/L ATP). After the intervention, cardiac function, myocardial injury and inflammatory factor markers were detected. The tissue sections were prepared to examine pathological changes, myocardial fibrosis, type Ⅰ and type Ⅲ collagen (COL1A1, COL3A1). Western blotting was performed to detecte the protein expression of P2X7R, NLRP3, tumor necrosis factor-α(TNF-α), interleukin-1β(IL-1β), and the expression of activated Caspase-1.  Results Compared with the sham surgery group, the AMI group showed an increase in the left ventricular end diastolic diameter (LVEDD), the coatent of brain natriuretic peptide (BNP) and cardiac troponin Ⅰ (cTnⅠ), fibrosis volume fraction, the positive expression of COL1A1, COL3A1, TNF-α, IL-1β, P2X7R, NLRP3, and activated Caspase-1 proteins (P<0.05), and a decrease in left ventricular ejection fraction (LVEF) (P<0.05). The HSY-low group, HSY-high groups, and compound miltiorhiza group showed a decrease in LVEDD, the content of BNP and cTnⅠ, fibrosis volume fraction, the positive expression of COL1A1 and COL3A1, TNF-α, IL-1β, P2X7R, NLRP3, and activated Caspase-1 proteins (P<0.05), and an increase in LVEF than these in the AMI group (P<0.05). The HSY-high+ATP group showed an increase in LVEDD, the content of BNP, cTnⅠ, fibrosis volume fraction, the positive expression of COL1A1 and COL3A1, TNF-α, IL-1β, P2X7R, NLRP3, and activated Caspase-1 proteins (P<0.05), and a decrease in LVEF than those in the HSY-high group (P<0.05).   Conclusion HSY inhibits P2X7R/NLRP3 pathway to alleviate myocardial fibrosis in AMI rats. 

Key words

Myocardial fibrosis
/ P2X purinoceptor 7/NOD-like receptor protein 3 pathway / Huangqi Shengmai Yin / Acute myocardial infarction / Western blotting / Rat

Cite this article

Download Citations
MA Yi-jie ZHANG You-jian WANG Ji-pei LI Dan-dan JIN Jin-ge. Effect of Huangqi Shengmai Yin on myocardial fibrosis in rats with acute myocardial infarction by adjusting P2X7R/NLRP3 pathway[J]. Acta Anatomica Sinica. 2025, 56(6): 713-720 https://doi.org/10.16098/j.issn.0529-1356.2025.06.011

References

 [1]Lv M, Yang D, Ji X, et al. Effect of WenXin KeLi on improvement of arrhythmia after myocardial infarction by intervening PI3K-AKT-mTOR autophagy pathway[J]. Evid Based Complement Alternat Med, 2022, 2022:2022970-2022983.
 [2] Yuan YH, Yuan R, Miao Y, et al. Effect and mechanism of Huangqi Shengmai Decoction in treatment of joint rat model of fatigue and myocardial injury[J]. China Journal of Chinese Materia Medica, 2022, 47(19):5292-5298. (in Chinese) 
袁亚慧, 袁蓉, 缪宇, 等. 黄芪生脉饮对疲劳合并心肌损伤大鼠模型的作用及相关机制[J].中国中药杂志, 2022, 47(19):5292-5298.
 [3] Song W, Dai B, Dai Y. Influence of ginsenoside Rh2 on cardiomyocyte pyroptosis in rats with acute myocardial infarction[J]. Evid Based Complement Alternat Med, 2022, 2022:5194523-5194532.
 [4] Li B, Yao BC, Chen QL, et al. The protective role and mechanism of liriodendrin in rats with myocardial infarction[J]. J Thorac Dis, 2022, 14(1):135-146.
 [5] Yu L, Yang Y, Wang J, et al. PDCD4 promotes inflammation/fibrosis by activating the PPAR-γ/NF-κB pathway in mouse atrial myocytes[J]. Mol Med Rep, 2024, 30(5):209-218.
 [6] Wang C, Cui C, Xie X, et al. Calcitriol attenuates lipopolysaccharide-induced neuroinflammation and depressive-like behaviors by suppressing the P2X7R/NLRP3/caspase-1 pathway[J]. Psychopharmacology (Berl), 2024, 241(7):1329-1343.
 [7] Zhang SJ, Huang CX, Zhao QY, et al. Macrophage colony-stimulating factor ameliorates myocardial injury in mice after myocardial infarction by regulating cardiac macrophages through the P2X7R/NLRP3/IL-1β signal pathway[J]. Heliyon, 2023, 9(10):e20805-e20814.
 [8] Xiao JL, Zou X, Dan JP. Effect of alfentanil on myocardial fibrosis in rats with acute myocardial infarction by regulating the SphK1/S1P signaling pathway[J]. China Jourmal of Chinese Materia Medica, 2024, 35(8):955-960. (in Chinese) 
肖锦亮, 邹雪, 但家朋. 阿芬太尼调节SphK1/S1P信号通路对急性心肌梗死大鼠心肌纤维化的影响[J]. 中国中药杂志, 2024, 35(8):955-960.
 [9] Duan YF, Gu J, Liu R, et al. Huangqi Shengmai Yin protects against radiation-induced cardiac inflammatory-fibrotic damage[J]. Traditional Chinese Drug Research and Clinical Pharmacology, 2020, 31(1):29-36. (in Chinese) 
段依璠, 顾静, 刘润, 等. 黄芪生脉饮防护放射诱导的心脏炎性-纤维化损伤作用研究[J]. 中药新药与临床药理, 2020, 31(1):29-36.
 [10] Lü YT, Wang YCh, Feng YD, et al. Study on the pharmacodynamics and mechanism of Blumea balsamifera total flavonoids against acute myocardial infarction model rats[J]. China Pharmacy, 2023, 34(11):1332-1336. (in Chinese) 
吕依婷, 王溢晨, 冯贻东, 等. 艾纳香总黄酮对急性心肌梗死模型大鼠的药效作用及机制研究[J]. 中国药房, 2023, 34(11):1332-1336.
 [11] Dai X, Fang X, Xia Y, et al. ATP-activated P2X7R promote the attack of acute gouty arthritis in rats through activating NLRP3 inflammasome and inflammatory cytokine production[J]. J Inflamm Res, 2022, 15(1):1237-1248.
 [12] Li XH, Xiang N. Effects of Danshensu on myocardial fibrosis in rats with acute myocardial infarction[J]. Journal of Chinese Medicinal Materials, 2020, 43(2):473-477. (in Chinese) 
李湘海, 向凝. 丹参素对急性心肌梗死大鼠心肌纤维化的影响[J]. 中药材, 2020, 43(2):473-477.
 [13] Han X, Yang Y, Zhang M, et al. Liquiritin protects against cardiac fibrosis after myocardial infarction by inhibiting CCL5 expression and the NF-κB signaling pathway[J]. Drug Des Devel Ther, 2022, 16(1):4111-4125.
 [14] Fang R, Ju D, Han M, et al. Progress on the role and mechanism of macrophage phenotypic changes in myocardial fibrosis[J]. Journal of Ningxia Medical University, 2024, 46(2):204-210. (in Chinese) 
方容, 鞠迪, 韩曼, 等. 巨噬细胞表型改变在心肌纤维化中的作用和机制研究进展[J]. 宁夏医科大学学报, 2024, 46(2):204-210.
 [15] Li J, Wang YQ, Zhan XH, et al. Summary of experience in the diagnosis and treatment of chronic heart failure[J]. Clinic Research of Tradition Chinese Medical, 2023, 15(36):56-60. (in Chinese)
李娟, 王昱琪, 战晓慧, 等. 辨治慢性心力衰竭经验摭拾[J]. 中医临床研究, 2023, 15(36):56-60.
 [16] Chen RSh, Xiao HZh, Liu N, et al. Effect of Shenqi Fuzheng injection on heart failure in mice by inhibiting ERK1/2, GATA4 signaling Pathways[J] Shanxi Journal of Traditional Chinese Medicine, 2022, 43(1):8-12. (in Chinese) 
陈仁山, 肖惠珍, 刘宁, 等. 参芪扶正注射液抑制ERK1/2,GATA4信号通路改善小鼠心力衰竭实验研究[J]. 陕西中医, 2022, 43(1):8-12.
 [17] Jiang JG, Du XM, Yao YM, et al. Effects of Huangqishengmaiyin on cardiac function, immune function and expression of plasma miRNA-155 in patients with coronary heart disease and heart failure[J]. Journal of Electrocardiology and Circulation, 2021, 40(3):262-266. (in Chinese) 
蒋健刚, 杜晓马, 姚宇玫, 等. 黄芪生脉饮对冠心病心力衰竭患者心功能,免疫功能和外周血miRNA-155表达的影响[J]. 心电与循环, 2021, 40(3):262-266.
 [18] Zhang G, Han X, Xu T, et al. Buyang Huanwu Decoction suppresses cardiac inflammation and fibrosis in mice after myocardial infarction through inhibition of the TLR4 signalling pathway[J]. J Ethnopharmacol, 2024, 320(1):117388-117398.
 [19] Zhang X, Tian B, Cong X, et al. SLIT3 promotes cardiac fibrosis and differentiation of cardiac fibroblasts by RhoA/ROCK1 signaling pathway[J]. Iran J Basic Med Sci, 2024, 27(7):832-840.
 [20] Zhang X, Qu H, Yang T, et al. LuQi formula ameliorates myocardial fibrosis by suppressing TLR4/MyD88/NF-κB pathway and NLRP3 inflammasome activation in mice with myocardial infarction[J]. Evid Based Complement Alternat Med, 2022, 2022(1):5867987-5867996.
 [21] Fan J, Ren M, Chen W, et al. Celastrol relieves myocardial infarction-induced cardiac fibrosis by inhibiting NLRP3 inflammasomes in rats[J]. Int Immunopharmacol, 2023, 121(1):110511-110520.
 [22] Zhou J, Tian G, Quan Y, et al. Inhibition of P2X7 purinergic receptor ameliorates cardiac fibrosis by suppressing NLRP3/IL-1β pathway[J]. Oxid Med Cell Longev, 2020, 2020(1):7956274-7956282.
 [23] Liu N, Gong Z, Li Y, et al. CTRP3 inhibits myocardial fibrosis through the P2X7R-NLRP3 inflammasome pathway in SHR rats[J]. J Hypertens, 2024, 42(2):315-328.
PDF(3812 KB)

Accesses

Citation

Detail

Sections
Recommended

/